| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +21,000 | 100% | $0.6212 | +$13,045 |
| Sells | 0 | ||||
| Net | +1 | +21,000 | 100% | +$13,045 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Ronald Hunt | Director | $483,028 | 13 Jan 2025 | ||
| Corey N. Fishman | Chief Executive Officer, Director | $191,887 | 06 Aug 2024 | ||
| Michael W. Dunne | Director | $88,013 | +$13,045 | +17% | 18 Nov 2025 |
| Beth Hecht | Director | $26,375 | 15 Jun 2023 | ||
| Mark Chin | Director | $25,628 | 15 Jun 2023 | ||
| Sailaja Puttagunta | Chief Medical Officer | $14,517 | 01 Dec 2023 | ||
| David G. Kelly | Director | 15 Jun 2022 | |||
| Joseph J. Whalen | Director | 10 Mar 2025 | |||
| Brenton K. Ahrens | Director | 23 Dec 2022 | |||
| Christine R. Coyne | Chief Commercial Officer | 01 Jul 2025 | |||
| Judith M. Matthews | Chief Financial Officer | 31 Mar 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael W. Dunne | ITRM | Ordinary Shares | Purchase | 2.55% | $2,191 | $0.3652 | 6,000 | 241,001 | 18 Nov 2025 | Direct |
| Michael W. Dunne | ITRM | Ordinary Shares | Purchase | 6.82% | $10,854 | $0.7236 | 15,000 | 235,001 | 08 Aug 2025 | Direct |
| Christine R. Coyne | ITRM | Share Option (Right to Buy) | Award | 200,000 | 200,000 | 01 Jul 2025 | Direct |